The MHC class II ligand lymphocyte activation gene-3 is co-distributed with CD8 and CD3-TCR molecules after their engagement by mAb or peptide-MHC class I complexes
- PMID: 10545478
- DOI: 10.1093/intimm/11.11.1745
The MHC class II ligand lymphocyte activation gene-3 is co-distributed with CD8 and CD3-TCR molecules after their engagement by mAb or peptide-MHC class I complexes
Abstract
Previous studies indicated that signaling through lymphocyte activation gene-3 (LAG-3), a MHC class II ligand, induced by multivalent anti-receptor antibodies led to unresponsiveness to TCR stimulation. Here, lateral distribution of the LAG-3 molecules and its topological relationship (mutual proximity) to the TCR, CD8, CD4, and MHC class I and II molecules were studied in the plasma membrane of activated human T cells in co-capping experiments and conventional fluorescence microscopy. Following TCR engagement by either TCR-specific mAb or MHC-peptide complex recognition in T-B cell conjugates, LAG-3 was found to be specifically associated with the CD3-TCR complex. Similarly, following CD8 engagement LAG-3 and CD8 were co-distributed on the cell surface while only a low percentage of CD4-capped cells displayed LAG-3 co-caps. In addition, LAG-3 was found to be associated with MHC class II (i.e. DR, DP and DQ) and partially with MHC class I molecules. The supramolecular assemblies described here between LAG-3, CD3, CD8 and MHC class II molecules may result from an organization in raft microdomains, a phenomenon known to regulate early events of T cell activation.
Similar articles
-
T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts.Eur J Cancer. 2001 Sep;37(13):1709-18. doi: 10.1016/s0959-8049(01)00184-8. Eur J Cancer. 2001. PMID: 11527700
-
Lymphocyte-activation gene 3/major histocompatibility complex class II interaction modulates the antigenic response of CD4+ T lymphocytes.Eur J Immunol. 1994 Dec;24(12):3216-21. doi: 10.1002/eji.1830241246. Eur J Immunol. 1994. PMID: 7805750
-
LAP, a lymphocyte activation gene-3 (LAG-3)-associated protein that binds to a repeated EP motif in the intracellular region of LAG-3, may participate in the down-regulation of the CD3/TCR activation pathway.Eur J Immunol. 2001 Oct;31(10):2885-91. doi: 10.1002/1521-4141(2001010)31:10<2885::aid-immu2885>3.0.co;2-2. Eur J Immunol. 2001. PMID: 11592063
-
The roles of CD4 and CD8 in T cell activation.Semin Immunol. 1991 May;3(3):133-41. Semin Immunol. 1991. PMID: 1909592 Review.
-
Interplay between the TCR/CD3 complex and CD4 or CD8 in the activation of cytotoxic T lymphocytes.Immunol Rev. 1989 Jun;109:119-41. doi: 10.1111/j.1600-065x.1989.tb00022.x. Immunol Rev. 1989. PMID: 2527803 Review.
Cited by
-
LAG-3 in Cancer Immunotherapy.Curr Top Microbiol Immunol. 2011;344:269-78. doi: 10.1007/82_2010_114. Curr Top Microbiol Immunol. 2011. PMID: 21086108 Free PMC article. Review.
-
The negative regulatory function of the lymphocyte-activation gene-3 co-receptor (CD223) on human T cells.Immunology. 2005 Jun;115(2):170-8. doi: 10.1111/j.1365-2567.2005.02145.x. Immunology. 2005. PMID: 15885122 Free PMC article.
-
Roles, function and relevance of LAG3 in HIV infection.PLoS Pathog. 2019 Jan 17;15(1):e1007429. doi: 10.1371/journal.ppat.1007429. eCollection 2019 Jan. PLoS Pathog. 2019. PMID: 30653605 Free PMC article. Review.
-
Characterization of LAG-3, CTLA-4, and CD8+ TIL density and their joint influence on the prognosis of patients with esophageal squamous cell carcinoma.Ann Transl Med. 2019 Dec;7(23):776. doi: 10.21037/atm.2019.11.38. Ann Transl Med. 2019. PMID: 32042792 Free PMC article.
-
LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model.Oncotarget. 2015 Sep 29;6(29):27359-77. doi: 10.18632/oncotarget.4751. Oncotarget. 2015. PMID: 26318293 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous